Partial least squares Discriminant analysis on MS studies

This analysis uses the "muma" package of the R statistics environment (Reference)

Click on links below to perform analysis.

PLSDA	Study ID	Scaling	Study Title	MS Analysis Type
	ST002122	Auto Pareto Vast Median Range None	Functional metabolic molecules were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Cells metabolomics)	Reversed phase POSITIVE ION MODE
	ST002122	Auto Pareto Vast Median Range None	Functional metabolic molecules were identified as novel therapeutic targets to facilitate gemcitabine treatment against pancreatic cancer (Cells metabolomics)	Reversed phase NEGATIVE ION MODE